Role of polyanhydrides as localized drug carriers

Langer, 1990, New methods of drug delivery, Science, 249, 1527, 10.1126/science.2218494 Brem, 1990, Polymers to treat brain tumours, Biomaterials, 11, 699, 10.1016/0142-9612(90)90030-T Kavanagh, 2004, Local drug delivery in restenosis injury: thermoresponsive co-polymers as potential drug delivery systems, Pharmacol. Ther. (Oxf.), 102, 1, 10.1016/j.pharmthera.2003.01.001 Stephens, 2000, Investigation of the in vitro release of gentamicin from a polyanhydride matrix, J. Control. Release, 63, 305, 10.1016/S0168-3659(99)00205-9 Park, 1998, Biodegradable polyanhydride devices of cefazolin sodium, bupivacaine, and taxol for local drug delivery: preparation, and kinetics and mechanism of in vitro release, J. Control. Release, 52, 179, 10.1016/S0168-3659(97)00223-X Jampel, 1993, Glaucoma filtration surgery in nonhuman primates using taxol and etoposide in polyanhydride carriers, Invest. Ophthalmol. Visual Sci., 34, 3076 Dhanikula, 1999, Localized paclitaxel delivery, Int. J. Pharm., 183, 85, 10.1016/S0378-5173(99)00087-3 Surmodics, Enabling local drug delivery/implant device combination therapies, www.surmodics.com Accessed on July 15, 2004. Langer, 1998, Drug delivery and targeting, Nature, 392, 5 Angelova, 1999, Rationalizing the design of polymeric biomaterials, TIBB, Tech. Innov. Berufl. Bild., 17, 411 Uhrich, 1999, Polymeric systems for controlled drug release, Chem. Rev., 99, 3181, 10.1021/cr940351u A.J. Domb, M. Maniar, A.S.T. Haffer. Biodegradable polymer blends for drug delivery, U.S. patent 5, 919, 835, (1999). Rosen, 1983, Bioerodible polyanhydrides for controlled drug delivery, Biomaterials, 4, 131, 10.1016/0142-9612(83)90054-6 Guilford Pharmaceuticals, About GLIADEL® Wafer, www.gliadel.com Accessed on July 10, 2004. Gopferich, 2002, Polyanhydride degradation and erosion, Adv. Drug Deliv. Rev., 54, 911, 10.1016/S0169-409X(02)00051-0 Kumar, 2002, Polyanhydrides: an overview, Adv. Drug Deliv. Rev., 54, 889, 10.1016/S0169-409X(02)00050-9 Kumar, 2002, Analysis of fatty acid anhydrides and polyanhydrides, Anal. Chim. Acta, 465, 257, 10.1016/S0003-2670(02)00468-3 Bapat, 2004, Novel methods of drug delivery to solid tumors, 1 Moses, 2003, Advancing the field of drug delivery: taking aim at cancer, Cancer Cell Int., 4, 337, 10.1016/S1535-6108(03)00276-9 Lincoff, 1994, Local drug delivery for the prevention of restenosis. Fact, fancy, and future, Circulation, 90, 2070, 10.1161/01.CIR.90.4.2070 Vogelhuber, 2001, Programmable biodegradable implants, J. Control. Release, 73, 75, 10.1016/S0168-3659(01)00282-6 Lesniak, 2004, Targeted therapy for brain tumors, Nature Rev. Drug Discov., 3, 499, 10.1038/nrd1414 Domb, 1987, Polyanhydrides. I. Preparation of high molecular weight polyanhydrides, J. Polym. Sci., A, Polym. Chem., 25, 3373, 10.1002/pola.1987.080251217 Domb, 1989, Poly(anhydrides). 3. Poly(anhydrides) based on aliphatic-aromatic diacids, Macromolecules, 22, 3200, 10.1021/ma00198a002 D'Emanuele, 1992, Molecular weight changes in polymer erosion, Pharm. Res., 9, 1279, 10.1023/A:1015801216466 Mathiowitz, 1988, Polyanhydride microspheres as drug carriers. II. Microencapsulation by solvent removal, J. Appl. Polym. Sci., 35, 755, 10.1002/app.1988.070350316 Wang, 2002, Local drug delivery to the brain, Adv. Drug Deliv. Rev., 54, 987, 10.1016/S0169-409X(02)00054-6 Deng, 2002, Effect of gamma-radiation on a polyanhydride implant containing gentamicin sulfate, Int. J. Pharm., 232, 1, 10.1016/S0378-5173(01)00885-7 Domb, 1991, Polyanhydrides. IV. Unsaturated and crosslinked polyanhydrides, J. Polym. Sci., A, Polym. Chem., 29, 571, 10.1002/pola.1991.080290413 Domb, 1992, Synthesis and characterization of biodegradable aromatic anhydride copolymers, Macromolecules, 25, 12, 10.1021/ma00027a003 Teomim, 1999, Ricinoleic acid-based biopolymers, J. Biomed. Mater. Res., 45, 258, 10.1002/(SICI)1097-4636(19990605)45:3<258::AID-JBM14>3.0.CO;2-W Domb, 1993, Absorbable biopolymers derived from dimer fatty acids, J. Polym. Sci., A, Polym. Chem., 31, 1275, 10.1002/pola.1993.080310523 Teomim, 2001, Nonlinear fatty acid terminated polyanhydrides, Biomacromolecules, 2, 37, 10.1021/bm000081r Vogel, 2005, Synthesis of novel biodegradable polyanhydrides containing aromatic and glycol functionality for tailoring of hydrophilicity in controlled drug delivery devices, Biomaterials, 26, 721, 10.1016/j.biomaterials.2004.03.024 Yang, 2003, In vitro release and antibacterial activity of poly(oliec/linoleic acid dimer: sebacic acid)-gentamicin, Acta Pharmacol. Sin., 24, 306 Krasko, 2002, Polyanhydrides with hydrophobic terminals, Polym. Adv. Technol., 13, 960, 10.1002/pat.267 Kipper, 2004, Understanding polyanhydride blend phase behavior using scattering, microscopy, and molecular simulations, Polymer, 45, 3329, 10.1016/j.polymer.2004.03.052 Silviniak, 2002, Stereocomplexes of enantiomeric lactic acid and sebacic acid ester-anhydride triblock copolymers, Biomacromolecules, 3, 754, 10.1021/bm0200128 Shieh, 1994, Erosion of a new family of biodegradable polyanhydrides, J. Biomed. Mater. Res., 28, 1465, 10.1002/jbm.820281212 Tamada, 1993, Erosion kinetics of hydrolytically degradable polymers, Proc. Natl. Acad. Sci. U. S. A., 90, 552, 10.1073/pnas.90.2.552 Mathiowitz, 1990, Morphological characterization of bioerodible polymers. 1. Crystallinity of polyanhydride copolymers, Macromolecules, 23, 3212, 10.1021/ma00215a003 Shakesheff, 1995, In situ atomic force microscopy visualization of the degradation of melt-crystallized poly(sebacic anhydride), Macromolecules, 28, 1108, 10.1021/ma00108a044 Dang, 1996, Morphological characterization of polyanhydride biodegradable implant gliadel during in vitro and in vivo erosion using scanning electron microscopy, Pharm. Res., 13, 683, 10.1023/A:1016035229961 Leach, 1998, Degradation of double-walled polymer microspheres of PLLA and P(CPP:SA)20:80. I. In vitro degradation, Biomaterials, 19, 1973, 10.1016/S0142-9612(98)00108-2 Albertsson, 1997, Comparison between physical blending and copolymerzation of poly(trimethylene carbonate) and poly(adipic anhydride) with special regard to compatibility, morphology and degradation, J. Macromol. Sci., Pure Appl. Chem., 34, 1457, 10.1080/10601329708011056 Burkoth, 2000, Surface and bulk modifications to photocrosslinked polyanhydrides to control degradation behavior, J. Biomed. Mater. Res., 51, 352, 10.1002/1097-4636(20000905)51:3<352::AID-JBM8>3.0.CO;2-C San Roman, 1987, Thermal degradation of poly(o-methacryloyloxybenzoic acid), Polym. Degrad. Stab., 19, 161, 10.1016/0141-3910(87)90074-7 Domb, 1995, Biodegradable polymers derived from natural fatty acids, J. Polym. Sci., A, Polym. Chem., 33, 717, 10.1002/pola.1995.080330413 Akbari, 1998, Effect of geometry on the erosion characteristics of polyanhydride matrices, Int. J. Pharm., 160, 83, 10.1016/S0378-5173(97)00298-6 Gopferich, 1995, Modeling of polymer erosion in three dimensions: rotationally symmetric devices, AIChE J., 41, 2292, 10.1002/aic.690411012 Mathiowitz, 1992, Polyanhydride microspheres. IV. Morphology and characterization of system made by spray drying, J. Appl. Polym. Sci., 45, 125, 10.1002/app.1992.070450115 Tabata, 1993, Polyanhydride microspheres that display near-constant release of water-soluble model drug compounds, Pharm. Res., 10, 391, 10.1023/A:1018988222324 Siepmann, 2001, Mathematical modeling of bioerodible, polymeric drug delivery systems, Adv. Drug Deliv. Rev., 48, 229, 10.1016/S0169-409X(01)00116-8 Hopfenberg, 1976, Controlled release from erodible slabs, cylinders and spheres, 26 Cooney, 1972, Effect of geometry on dissolution of pharmaceutical tablets and other solids. Surface detachment kinetics controlling, AIChE J., 18, 446, 10.1002/aic.690180234 Gopferich, 1995, Predicting drug release from cylindrical polyanhydride matrix discs, Eur. J. Pharm. Biopharm., 41, 81 Zygourakis, 1990, Development and temporal evolution of erosion fronts in bioerodible controlled release devices, Chem. Eng. Sci., 45, 2359, 10.1016/0009-2509(90)80116-V Zygourakis, 1996, Computer-aided design of bioerodible devices with optimal release characteristics: a cellular automata approach, Biomaterials, 17, 125, 10.1016/0142-9612(96)85757-7 Gopferich, 1993, Modeling of polymer erosion, Macromolecules, 26, 4105, 10.1021/ma00068a006 Domb, 1995, In vivo and in vitro elimination of aliphatic polyanhydrides, Biomaterials, 16, 319, 10.1016/0142-9612(95)93260-K Katti, 2002, Toxicity, biodegradation and elimination of polyanhydrides, Adv. Drug Deliv. Rev., 54, 933, 10.1016/S0169-409X(02)00052-2 Domb, 1994, Metabolic disposition and elimination studies of a radiolabelled biodegradable polymeric implant in the rat brain, Biomaterials, 15, 681, 10.1016/0142-9612(94)90166-X Leong, 1986, Bioerodible polyanhydrides as drug carrier matrices. II. Biocompatibilty and chemical reactivity, J. Biomed. Mater. Res., 20, 51, 10.1002/jbm.820200106 Laurencin, 1990, Poly(anhydride) administration in high doses in vivo: studies of biocompatibility and toxicology, J. Biomed. Mater. Res., 24, 1463, 10.1002/jbm.820241105 Tamargo, 1989, Brain biocompatibility of a biodegradable, controlled-release polymer in rats, J. Biomed. Mater. Res., 23, 253, 10.1002/jbm.820230209 Brem, 1989, Biocompatibility of a biodegradable, controlled-release polymer in the rabbit brain, Sel. Cancer Ther., 5, 55, 10.1089/sct.1989.5.55 Krasko, 2003, Poly(ester anhydride)s prepared by the insertion of ricinoleic acid into poly(sebacic acid), J. Polym. Sci., A, Polym. Chem., 41, 1059, 10.1002/pola.10651 Li, 2004, Treatment of intracranial rat glioma model with implant of radiosensitizer and biomodulator drug combined with external beam radiotherapy, Int. J. Radiat. Oncol. Biol. Phys., 58, 519, 10.1016/j.ijrobp.2003.09.054 Berrada, 2002, Tumor treatment by sustained intratumoral release of 5-fluorouracil: Effects of drug alone and in combined treatments, Int. J. Radiat. Oncol. Biol. Phys., 54, 1550, 10.1016/S0360-3016(02)03740-9 Storm, 2002, Polymer delivery of camptothecin against 9 l gliosarcoma: release, distribution, and efficacy, J. Neurol., 56, 209 Shikanov, 2004, Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for paclitaxel: in vitro release and in vivo toxicity, J. Biomed. Mater. Res., 69A, 47, 10.1002/jbm.a.20101 Shikani, 2000, Polymer chemotherapy for head and neck cancer, Laryngoscope, 110, 907, 10.1097/00005537-200006000-00004 Maniar, 1994, Controlled release of a local anesthetic from fatty acid dimer based polyanhydride, J. Control. Release, 30, 233, 10.1016/0168-3659(94)90029-9 Masters, 1993, Sustained local anesthetic release from bioerodible polymer matrices: a potential method for prolonged regional anesthesia, Pharm. Res., 10, 1527, 10.1023/A:1018995913972 Guo, 2004, New polyanhydrides derived from C12,C13,C14,C15 dibasic acid: synthesis and characterization, Polymer, 45, 5743, 10.1016/j.polymer.2004.04.028 Teomim, 1999, Perivascular delivery of heparin for the reduction of smooth muscle cell proliferation after endothelial injury, J. Control. Release, 60, 129, 10.1016/S0168-3659(99)00071-1 Orloff, 1997, Biodegradable implant strategies for inhibition of restenosis, Adv. Drug Deliv. Rev., 24, 3, 10.1016/S0169-409X(96)00478-4 Quick, 2004, Delivering DNA from photocrosslinked, surface eroding polyanhydrides, J. Control. Release, 97, 333, 10.1016/j.jconrel.2004.03.001 Uppal, 1994, Pharmacokinetics of etoposide delivery by a bioerodible drug carrier implanted at glaucoma surgery, J. Ocul. Pharmacol., 10, 471, 10.1089/jop.1994.10.471 Anastasiou, 2003, Aminosalicylate-based biodegradable polymers: syntheses and in vitro characterization of poly(anhydride-ester)s and poly(anhydrie-amide)s, J. Polym. Sci., A, Polym. Chem., 41, 3667, 10.1002/pola.10973 Mylonas, 1995, Preparation and evaluation of polyanhydride microspheres containing gonadotropin-releasing hormone (GnRH), for inducing ovulation and spermiation in fish, J. Control. Release, 35, 23, 10.1016/0168-3659(95)00009-W Howard, 1989, Intracerebral drug delivery in rats with lesion-induced memory deficits, J. Neurosurg., 71, 105, 10.3171/jns.1989.71.1.0105 Giralami, 2000, The central nervous system, 1293 Calabresi, 2001, Chemotherapy of neoplastic diseases, 1381 Black, 1991, Brain tumors. Part 1, N. Engl. J. Med., 324, 1471, 10.1056/NEJM199105233242105 Saltzman, 1997, Polymeric implants for cancer chemotherapy, Adv. Drug Deliv. Rev., 26, 209 Singla, 2002, Paclitaxel and its formulations, Int. J. Pharm., 235, 179, 10.1016/S0378-5173(01)00986-3 1989 Dordunoo, 1997, Release of taxol from poly(ε-caprolactone) pastes: effect of water-soluble additives, J. Control. Release, 44, 87, 10.1016/S0168-3659(96)01510-6 Senior, 2000, Glioblastoma: encouraging the body to fight back, PSTT, 3, 189 Rostomily, 1996, Radical surgery in the management of low-grade and high-grade gliomas, Bailliere's Clin. Neurol., 5, 345 Chang, 1983, Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint radiation therapy oncology group and eastern cooperative oncology group study, Cancer, 52, 997, 10.1002/1097-0142(19830915)52:6<997::AID-CNCR2820520612>3.0.CO;2-2 Green, 1983, Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma, Cancer Treat. Rep., 67, 121 Kornblith, 1988, Chemotherapy for malignant gliomas, J. Neurosurg., 68, 1, 10.3171/jns.1988.68.1.0001 Walker, 1978, Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial, J. Neurosurg., 49, 333, 10.3171/jns.1978.49.3.0333 Walker, 1980, Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery, N. Engl. J. Med., 303, 1323, 10.1056/NEJM198012043032303 Barker, 1998, Survival and functional status after resection of recurrent glioblastoma multiforme, Neurosurgery, 42, 709, 10.1097/00006123-199804000-00013 Mohan, 1998, Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution, Int. J. Radiat. Oncol. Biol. Phys., 42, 981, 10.1016/S0360-3016(98)00296-X Greig, 1987, Optimizing drug delivery to brain tumors, Cancer Treat. Rev., 14, 1, 10.1016/0305-7372(87)90048-X Abbott, 1996, Transporting therapeutics across the blood-brain barrier, Mol. Med. Today, 2, 106, 10.1016/1357-4310(96)88720-X Chasin, 1990, Interstitial drug therapy for brain tumors: a case study, Drug Dev. Ind. Pharm., 16, 2579, 10.3109/03639049009058548 Domb, 1999, Preparation and characterization of carmustine loaded polyanhydride wafers for treating brain tumors, Pharm. Res., 16, 762, 10.1023/A:1011995728760 Ron, 1991, NMR characterization of erodible copolymers, Macromolecules, 24, 2278, 10.1021/ma00009a024 Dang, 1996, Effects of GLIADEL® wafer initial molecular weight on the erosion of wafer and release of BCNU, J. Control. Release, 42, 83, 10.1016/0168-3659(96)01371-5 Katti, 2002, Toxicity, biodegradation and elimination of polyanhydride, Adv. Drug Deliv. Rev., 54, 933, 10.1016/S0169-409X(02)00052-2 Brem, 1994, Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain, J. Neurosurg., 80, 283, 10.3171/jns.1994.80.2.0283 Rhines, 2000, O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat glioma, Cancer Res., 60, 6307 Frazier, 2003, Local delivery of minocycline and systemic BCNU have synergistic activity in the treatment of intracranial glioma, J. Neurol., 64, 203 Tamargo, 1990, Growth inhibition of the 9l glioma using polymers to release heparin and cortisone acetate, J. Neurol., 9, 131 Walter, 1994, Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma, Cancer Res., 54, 2207 Judy, 1995, Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas, J. Neurosurg., 82, 481, 10.3171/jns.1995.82.3.0481 Sipos, 2001, l-buthionine sulfoximine potentiates the antitumor effect of 4-hydroperoxycyclophosphamide when administered locally in a rat glioma model, Neurosurgery, 48, 392 Colvin, 1993, Role of glutathione in cellular resistance to alkylating agents, Adv. Enzyme Regul., 33, 19, 10.1016/0065-2571(93)90006-Y Choti, 1995, Intrahepatic FUdR delivered from biodegradable polymer in experimental liver metastases from colorectal carcinoma, Proc. Am. Assoc. Cancer Res., 36, 309 Williams, 1997, Implantable biodegradable polymers for IUdR radiosensitization of experimental human malignant glioma, J. Neurol., 32, 181 Chabner, 2001, Antineoplastic agents, 1389 Olivi, 1996, Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat, Cancer Chemother. Pharmacol., 39, 90, 10.1007/s002800050542 Shikani, 1994, Polymer delivery of chemotherapy for squamous cell carcinoma of the head and neck, Arch. Otolaryngol. Head Neck Surg., 120, 1242, 10.1001/archotol.1994.01880350050009 Li, 2002, Polyanhydride implant for antibiotic delivery—from the bench to the clinic, Adv. Drug Deliv. Rev., 54, 963, 10.1016/S0169-409X(02)00053-4 Tian, 2002, The effect of storage temperatures on the in vitro properties of a polyanhydride implant containing gentamicin, Drug Dev. Ind. Pharm., 28, 897, 10.1081/DDC-120006422 Nobuyoshi, 1988, Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients, J. Am. Coll. Cardiol., 12, 616, 10.1016/S0735-1097(88)80046-9 Haung, 2002, Optimization of local methylprednisolone delivery to inhibit inflammatory reaction and neointimal hyperplasia of coated coronary stents, J. Invasive Cardiol., 14, 503 Toutouzas, 2004, Inflammation and restenosis after percutaneous coronary interventions, Eur. Heart J., 25, 1679, 10.1016/j.ehj.2004.06.011 Haudenschild, 1993, Pathobiology of restenosis after angioplasty, Am. J. Med., 94, 40S Lovqvist, 1993, Pathophysiological mechanisms for restenosis following coronary angioplasty: possible preventive alternatives, J. Intern. Med., 233, 215, 10.1111/j.1365-2796.1993.tb00979.x Koster, 1995, Enhanced migratory activity of vascular smooth muscle cells with high expression of platelet-derived growth factor A and B, Angiology, 46, 99, 10.1177/000331979504600202 Wilcox, 1991, Thrombin and other potential mechanisms underlying restenosis, Circulation, 84, 432, 10.1161/01.CIR.84.1.432 Gershlick, 2002, Treating atherosclerosis: local drug delivery from laboratory studies to clinical trials, Atherosclerosis, 160, 259, 10.1016/S0021-9150(01)00618-9 Bennett, 2001, Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy, Pharmacol. Ther., 91, 149, 10.1016/S0163-7258(01)00153-X Herrman, 1993, Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part II), Drugs, 46, 249, 10.2165/00003495-199346020-00003 Marmur, 1994, Thrombin generation in human coronary arteries after percutaneous transluminal balloon angioplasty, J. Am. Coll. Cardiol., 24, 1484, 10.1016/0735-1097(94)90144-9 Mathias, 1991, Local thrombolysis for salvage of occluded bypass grafts, Semin. Thromb. Hemost., 17, 14, 10.1055/s-2007-1002586 Wilcox, 1993, Molecular biology: insight into the causes and prevention of restenosis after arterial intervention, Am. J. Cardiol., 72, 88E, 10.1016/0002-9149(93)91043-H Muller, 1994, Gene therapy for cardiovascular disease, Br. Heart J., 72, 309, 10.1136/hrt.72.4.309 Nabel, 1990, Site-specific gene expression in vivo by direct gene transfer into the arterial wall, Science, 249, 1285, 10.1126/science.2119055 Nabel, 1995, Gene therapy for cardiovascular disease, Circulation, 91, 541, 10.1161/01.CIR.91.2.541 Bennett, 1994, Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides, J. Clin. Invest., 93, 820, 10.1172/JCI117036 Edelman, 1995, C-myc in vasculoproliferative disease, Circ. Res., 76, 176, 10.1161/01.RES.76.2.176 Epstein, 1993, Do antisense approaches to the problem of restenosis make sense?, Circulation, 88, 1351, 10.1161/01.CIR.88.3.1351 Feldman, 1995, Gene therapy for the vulnerable plaque, J. Am. Coll. Cardiol., 26, 826, 10.1016/0735-1097(95)00235-V Mitchel, 1994, Inhibition of platelet deposition and lysis of intracoronary thrombus during balloon angioplasty using urokinase-coated hydrogel balloons, Circulation, 90, 1979, 10.1161/01.CIR.90.4.1979 Sigwart, 1987, Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty, N. Engl. J. Med., 316, 701, 10.1056/NEJM198703193161201 Labhasetwar, 1997, Nanoparticle drug delivery system for restenosis, Adv. Drug Deliv. Rev., 24, 63, 10.1016/S0169-409X(96)00483-8 Domb, 1994, Polymers for site-specific drug delivery, 1 Orloff, 1995, Prevention of venous thrombosis in microvascular surgery by transmural release of heparin from a polyanhydride polymer, Surgery, 117, 554, 10.1016/S0039-6060(05)80255-7 Lee, 1988, The use of bioerodible polymers and 5-fluorouracil in glaucoma filtration surgery, Invest. Ophthalmol. Vis. Sci., 29, 1692 Jampel, 1990, Glaucoma filtration surgery in monkeys using 5-fluorouridine in polyanhydride disks, Arch. Ophthalmol., 108, 430, 10.1001/archopht.1990.01070050128046 Herrero-Vanrell, 2001, Biodegradable microspheres for vitreoretinal drug delivery, Adv. Drug Deliv. Rev., 52, 5, 10.1016/S0169-409X(01)00200-9 Dang, 1994, Controlled release of macromolecules from a degradable polyanhydride matrix, J. Biomater. Sci., Polym. Ed., 6, 297, 10.1163/156856294X00374 Hanes, 1998, Degradation of porous poly(anhydride-co-imide) microspheres and implications for controlled macromolecule delivery, Biomaterials, 19, 163, 10.1016/S0142-9612(97)00221-4 Tabata, 1993, Controlled delivery systems for proteins using polyanhydride microspheres, Pharm. Res., 10, 487, 10.1023/A:1018929531410 Lucas, 1990, Ectopic induction of cartilage and bone by water-soluble proteins from bovine bone using a polyanhydride delivery vehicle, J. Biomed. Mater. Res., 24, 901, 10.1002/jbm.820240708 Jiang, 2000, Pulsatile protein release from a laminated device comprising polyanhydrides and pH-sensitive complexes, Int. J. Pharm., 194, 51, 10.1016/S0378-5173(99)00336-1 Kubek, 1998, Prolonged seizure suppression by a single implantable polymeric-TRH microdisk preparation, Brain Res., 809, 189, 10.1016/S0006-8993(98)00860-9 Allard, 2004, Antigenicity of recombinant proteins after regioselective immobilization onto polyanhydride-based copolymers, Bioconjug. Chem., 15, 458, 10.1021/bc034146+ Cai, 2003, Synthesis, characterization and in vitro release of 5-aminosalicylic acid and 5-acetyl aminosalicylic acid of polyanhydride-P(CBFAS), Eur. J. Pharm. Biopharm., 55, 203, 10.1016/S0939-6411(02)00191-1